Association of cannabis with chronic obstructive pulmonary disease and COVID-19 infection

作     者：Steven Lehrer Peter H.Rheinstein Steven Lehrer;Peter H. Rheinstein

作者机构：Department of Radiation OncologyIcahn School of Medicine at Mount SinaiNew YorkNew YorkUSA Severn Health SolutionsSeverna ParkMarylandUSA 

出 版 物：《Chronic Diseases and Translational Medicine》 (慢性疾病与转化医学（英文版）)

年 卷 期：2022年第8卷第3期

页      面：238-241页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：Office of Research Infrastructure of the National Institutes of Health(Grant/Award Number:S10OD018522 S10OD026880) 

主　　题：cannabis COPD COVID-19 lungs tobacco 

摘      要：In a 2012 study,occasional and low cumulative cannabis use was not associated with adverse effects on pulmonary function. With tobacco,the more used,the more loss of air flow rate and lung *** same was not true with cannabis *** flow rate increased rather than decreased with increased exposure to cannabis up to a certain level.